Gonadotropin-releasing hormone (GnRH)
Gonadotropin-releasing hormone (GnRH) is a crucial hormone that plays a significant role in regulating the reproductive system in both men and women. Produced by nerve cells in the hypothalamus, GnRH stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are essential for processes like egg maturation and sperm production. The release of GnRH occurs in a pulsatile manner, varying between genders and across different life stages, particularly during puberty. Conditions like hypogonadism can lead to insufficient GnRH production, resulting in delayed puberty or reproductive issues. Conversely, excessive GnRH can arise from tumors and lead to hormonal imbalances.
As a therapeutic agent, GnRH can be administered to address hormonal imbalances, treat infertility, or manage conditions like endometriosis and prostate cancer. Medications, including GnRH agonists and antagonists, are often used in fertility treatments, helping to regulate the ovulatory cycle. While these treatments can enhance the likelihood of conception, they may also come with side effects, such as mood changes and headaches. Overall, GnRH is fundamental to reproductive health, influencing various physiological processes across different stages of life.
Gonadotropin-releasing hormone (GnRH)
Gonadotropin-releasing hormone (GnRH) is a type of hormone that stimulates the release of the follicle-stimulating hormone (FSH) and luteinising hormone (LH). GnRH is a vital part of the male and female reproduction systems, linked to the menstrual cycle and conception in women and to sperm production in men. Specific conditions can cause the body to release too little or too much GnRH. As a drug, GnRH can be used to delay puberty and treat hormonal imbalances or infertility problems.
Overview
Nerve cells in the hypothalamus in the brain are responsible for releasing pulses of GnRH. The hypothalamus links the nervous system with the endocrine system via the pituitary gland. When it is released into the blood vessels, GnRH sends signals to the pituitary gland to produce FSH and LH. These hormones help to begin and maintain reproductive functions. The hormones work differently in men's and women's bodies. In women, these hormones cause the ovaries to mature and release an egg during the menstrual cycle. In men, they cause the testes to mature and produce sperm cells. FSH and LH also stimulate the ovaries to release estrogen, progesterone, and testosterone and cause the testes to produce testosterone and estrogen.
The pulses of GnRH released vary by gender. In women, they are released according to the menstrual cycle. For example, prior to ovulation, the pulses come at a more frequent pace. In men, the pulses mostly come at the same consistent rate. In addition, the levels of GnRH released change over time. A child usually has low levels of GnRH, but the levels increase as the child ages, which signals the body to begin puberty, or sexual maturation. When a person's body reaches full sexual maturity (when the ovaries or testes are fully developed), the levels of testosterone in men and estrogen and progesterone in women control the production of GnRH. For instance, when a man's testosterone level rises, his body produces less GnRH. When a woman's estrogen and progesterone levels decrease, her body increases the production of GnRH. However, when a woman's body reaches the midpoint of her menstrual cycle, her oestradiol levels are very high. These high levels cause an increase in GnRH and LH secretion, which triggers the release of a mature egg in a process called ovulation.
Sometimes the body's levels of GnRH are too low or too high. If a child has hypogonadism, or too little GnRH, he or she will not reach puberty. Several genetic conditions such as Kallmann, Turner, and Klinefelter syndromes can cause low levels of GnRH because the body is not able to develop GnRH-producing nerve cells and, therefore, cannot go through puberty. Brain injuries in which the hypothalamus is affected also can cause the body to secrete little or no GnRH, which will halt the release of FSH and LH and lead to various issues. Women may experience amenorrhoea, or the absence of the menstrual cycle, or loss of hormone production from the ovaries. Men may not produce sperm or experience a loss of hormone production from the testes.
Tumors also can affect GnRH production. Too much GnRH in the body may be caused by tumors on the pituitary gland or other medical conditions. This can lead to an increased production of hormones such as testosterone or estrogen.
Gonadotropin-Releasing Hormone as a Drug
GnRH may also be used as a medication to treat several health conditions. Children with delayed puberty or adults with suspected hormonal imbalances may receive the medications luliberin or gonadorelin intravenously as part of treatment. A lutrepulse pump may be used in men who do not produce enough sperm or in women who do not ovulate.
More commonly, GnRH agonists and GnRH antagonists may be used as medications to treat infertility in women. Given as injections, they are usually used in conjunction with other infertility procedures such as in vitro fertilization (IVF), in which an egg is fertilized outside the body and then implanted in the body to achieve pregnancy. Both GnRH agonists and GnRH antagonists are used to control the ovulatory cycle; they cause the body to enter temporary menopause, or the stoppage of ovulation and menstruation.
GnRH agonists cause the body to overproduce FSH and LH. This surge in hormones causes the pituitary gland to shut down, which stops the production of FSH and LH and ceases ovulation. GnRH antagonists do not produce an initial overproduction of FSH and LH. They just block the effects the hormones have on the pituitary gland, which causes it to stop making FSH and LH and halts ovulation. GnRH antagonists work much more quickly than GnRH agonists, which can take a few days to halt ovulation.
After ovulation is ceased, an ovulation-stimulating medicine is used to restart ovulation, so the body can begin to produce eggs. These eggs then can be fertilized to produce a pregnancy. Both GnRH agonists and antagonists are used to increase the chances a woman will become pregnant either naturally or through an infertility procedure.
Several risks, such as conceiving a multiple pregnancy, are associated with taking GnRH agonists and GnRH antagonists. These medications can also cause several minor side effects, which usually go away when the medications are stopped. Some side effects include the following:
cholesterol changes, such as increased low-density lipoprotein (LDL) or decreased high-density lipoprotein (HDL)
headaches
hot flashes
mood changes
nausea
sexual problems, such as decreased libido or vaginal dryness
sleep changes
itching, redness, or swelling at the injection site
GnRH agonists may be used to treat other conditions such as endometriosis, fibroids, and prostate cancer. They can be used to delay the onset of puberty in very young children or in transgender adolescents who do not want to develop secondary sex characteristics.
Bibliography
Ellis, Mary Ellen. "LH Response to GnRH Test." Healthline, 12 Feb. 2016, www.healthline.com/health/lh-response-to-gnrh#Overview1. Accessed 10 Jan. 2017.
"Gonadotrophin-Releasing Hormone." You & Your Hormones, 31 Mar. 2015, www.yourhormones.info/hormones/gonadotrophinreleasing‗hormone.aspx. Accessed 10 Jan. 2017.
"Gonadotropin-Releasing Hormone Analogues for Infertility." University of Michigan, 19 Mar. 2010, www.uofmhealth.org/health-library/tn9637. Accessed 10 Jan. 2017.
"Gonadotropin Releasing Hormones." Drugs.com, www.drugs.com/drug-class/gonadotropin-releasing-hormones.html. Accessed 10 Jan. 2017.
Gurevich, Rachel. "Gonadotropin-Releasing Hormone (GnRH)." Verywell, 11 Feb. 2016, www.verywell.com/gonadotropin-releasing-hormone-gnrh-1960075. Accessed 10 Jan. 2017.
Korry, Elaine. "Can Delaying Puberty Help Transgender Kids?" Daily Beast, 11 Aug. 2016, www.thedailybeast.com/articles/2016/08/11/can-delaying-puberty-help-transgender-kids.html. Accessed 10 Jan. 2017.
Moghissi, Kamran S. "A Clinician's Guide to the Use of Gonadotropin-Releasing Hormone Analogues in Women." Medscape, www.medscape.com/viewarticle/408909. Accessed 10 Jan. 2017.
Popat, Vaishali, et al. "Gonadotropin-Releasing Hormone Deficiency in Adults." Medscape, 11 Nov. 2013, emedicine.medscape.com/article/255152-overview. Accessed 10 Jan. 2017.